Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

In females, 1-methyladenosine was negatively correlated with 1,25-dihydroxyvitamin D3 and ergothioneine (Fig. 3i).

Source: Increased RNA turnover. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants aged 18 to 70 years with depression unresponsive to known treatments (at least three maximum dose medication trials for at least 6 weeks each) were recruited by advertisement through the Clinical and Translational Science Institute Registry at the University of Pittsburgh or by clinical referral.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Metabolic features of treatment-refractory major depressive disorder with suicidal ideation

Study design awaiting verification · Translational Psychiatry · 2023

Original publication title

Metabolic features of treatment-refractory major depressive disorder with suicidal ideation

Lisa A. Pan; Jane C. Naviaux; Lin Wang; Kefeng Li; Jonathan M. Monk; Sai Sachin Lingampelly; Anna Maria Segreti; Kaitlyn Bloom; Jerry Vockley; Mark A. Tarnopolsky; David N. Finegold; David G. Peters; Robert K. Naviaux

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Peripheral blood metabolomics was used to gain chemical insight into the biology of treatment-refractory Major Depressive Disorder with suicidal ideation, and to identify individualized differences for personalized care. The study cohort consisted of 99 patients with treatment-refractory major depressive disorder and suicidal ideation (trMDD-SI n = 52 females and 47 males) and 94 age: and sex-matched healthy controls (n = 48 females and 46 males). The median age was 29 years (IQR 22 to 42). Targeted, broad-spectrum metabolomics measured 448 metabolites.

Fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) were measured as biomarkers of mitochondrial dysfunction. The diagnostic accuracy of plasma metabolomics was over 90% (95%CI: 0.80 to 1.0) by area under the receiver operator characteristic (AUROC) curve analysis. Over 55% of the metabolic impact in males and 75% in females came from abnormalities in lipids. Modified purines and pyrimidines from tRNA, rRNA, and mRNA turnover were increased in the trMDD-SI group. FGF21 was increased in both males and females.

Increased lactate, glutamate, and saccharopine, and decreased cystine provided evidence of reductive stress. Seventy-five percent of the metabolomic abnormalities found were individualized. Personalized deficiencies in CoQ10, flavin adenine dinucleotide (FAD), citrulline, lutein, carnitine, or folate were found. Pathways regulated by mitochondrial function dominated the metabolic signature. Peripheral blood metabolomics identified mitochondrial dysfunction and reductive stress as common denominators in suicidal ideation associated with treatment-refractory major depressive disorder. Individualized metabolic differences were found that may help with personalized management.

Authors’ abstract

Peripheral blood metabolomics was used to gain chemical insight into the biology of treatment-refractory Major Depressive Disorder with suicidal ideation, and to identify individualized differences for personalized care. The study cohort consisted of 99 patients with treatment-refractory major depressive disorder and suicidal ideation (trMDD-SI n = 52 females and 47 males) and 94 age: and sex-matched healthy controls (n = 48 females and 46 males). The median age was 29 years (IQR 22 to 42). Targeted, broad-spectrum metabolomics measured 448 metabolites.

Fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) were measured as biomarkers of mitochondrial dysfunction. The diagnostic accuracy of plasma metabolomics was over 90% (95%CI: 0.80 to 1.0) by area under the receiver operator characteristic (AUROC) curve analysis. Over 55% of the metabolic impact in males and 75% in females came from abnormalities in lipids. Modified purines and pyrimidines from tRNA, rRNA, and mRNA turnover were increased in the trMDD-SI group. FGF21 was increased in both males and females.

Increased lactate, glutamate, and saccharopine, and decreased cystine provided evidence of reductive stress. Seventy-five percent of the metabolomic abnormalities found were individualized. Personalized deficiencies in CoQ10, flavin adenine dinucleotide (FAD), citrulline, lutein, carnitine, or folate were found. Pathways regulated by mitochondrial function dominated the metabolic signature. Peripheral blood metabolomics identified mitochondrial dysfunction and reductive stress as common denominators in suicidal ideation associated with treatment-refractory major depressive disorder. Individualized metabolic differences were found that may help with personalized management.

Publication and source details

Original title: Metabolic features of treatment-refractory major depressive disorder with suicidal ideation

Lisa A. Pan; Jane C. Naviaux; Lin Wang; Kefeng Li; Jonathan M. Monk; Sai Sachin Lingampelly; Anna Maria Segreti; Kaitlyn Bloom; Jerry Vockley; Mark A. Tarnopolsky; David N. Finegold; David G. Peters; Robert K. Naviaux

Translational Psychiatry · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.The UCSD Christini Fund The William Wright Family Foundation The Lennox Foundation The UCSD Mitochondrial Disease Research Foundationhttps://doi.org/10.13039/100001455American Foundation for Suicide Prevention (AFSP)https://doi.org/10.13039/100010559Pitt | University of Pittsburgh Medical Center | Children’s Hospital of Pittsburghhttps://doi.org/10.13039/100000874Brain and Behavior Research Foundation (Brain & Behavior Research Foundation)NARSAD AwardPan Lisa A. The Fine Foundation Suicide Rebellion Foundation American Foundation for Suicide Prevention Standard Research Award Brain and Behavior Research Foundationhttps://doi.org/10.13039/100010554Pitt | Clinical and Translational Science Institute, University of Pittsburgh (CTSI)UL1 RR024153UL1 TR000005Vockley Jerry

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T14:13:11.732145+00:00

DOI: 10.1038/s41398-023-02696-9 · PMC10721812